HOME >> MEDICINE >> NEWS
Gastric bypass works for GERD and obesity in patients with prior surgery, says Pitt study

PITTSBURGH, Nov. 15 Laparoscopic gastric bypass surgery can effectively control gastroesophageal reflux disease (GERD) symptoms in morbidly obese patients who had previous antireflux surgery, with the additional benefit of weight loss and improvement of co-morbidities, according to a study published in the November issue of the journal Obesity Surgery.

The University of Pittsburgh School of Medicine study found that gastric bypass is feasible and effective in controlling GERD in patients who had previous antireflux surgery and who have subsequently gained significant weight, and in obese patients who have had previous antireflux procedures and continued to have problems with GERD.

This small study involved seven patients who underwent laparoscopic gastric bypass after having antireflux surgery to control GERD. Patients' co-morbid medical conditions included sleep apnea, diabetes mellitus, hypertension, degenerative joint disease, depression, hypercholesterolemia, polycystic ovarian syndrome and lower extremity edema.

"Despite a morbidity rate of 42.8 percent, this study showed that all patients did well with zero mortality and were satisfied with their condition during the follow-up period, suggesting that the long-term outcome of laparoscopic gastric bypass in obese patients who had previous antireflux surgery is promising. There also was a significant improvement of GERD symptoms following the laparoscopic gastric bypass, which was maintained during follow-up," said Ioannis Raftopoulos, M.D., Ph.D., assistant professor of surgery in the division of thoracic & foregut surgery at the University of Pittsburgh School of Medicine, and principal author of the study. In addition, 70 percent of associated co-morbid medical conditions were either resolved or improved significantly.

GERD is a significant public health problem affecting up to 40 percent of the American adult population.

"Although a direct cause-effect relationship
'"/>


15-Nov-2004


Page: 1 2 3

Related medicine news :

1. Gastric bypass and stomach-stapling patients should recognize risk of nerve injury post-surgery
2. Gastric bypass surgery is riskiest for those who need it most
3. Gastric bypass surgery riskiest for those who need it most
4. Gastric bypass surgery resolves or improves diabetes in most patients, reports Pittsburgh study
5. Gastric bypass surgery for obesity may ease symptoms of gastroesophageal reflux disease
6. Drug And Radiation Treatment May Shrink Pancreatic And Gastric Tumors
7. Health care report cards may increase racial/ethnic disparities in bypass operations
8. Gender a factor in who gets bypass surgery
9. Angioplasty, robotically assisted keyhole bypass combo appears effective
10. Combining liver transplantation and coronary artery bypass grafting can be safe and effective
11. Laparoscopic gastric bypass surgery effectively improves obesity-related health problems

Post Your Comments:
(Date:3/6/2015)... Toronto, ON (PRWEB) March 06, 2015 ... with the Canadian Celiac Association, is pleased to ... founded by Dufflet Rosenberg, has expanded their product ... and they are as scrumptious and as satisfying ... is hand-crafted from scratch, and never contains hydrogenated ...
(Date:3/6/2015)... FL (PRWEB) March 06, 2015 The producers ... March 2015 air dates for Spokane, Washington and vicinity. This ... places to shop and dine, and many outdoor activities. It ... supporting the local economy. Six major hospitals call the city ... the Canadian border. The medically-focused cable TV program will be ...
(Date:3/6/2015)... March 06, 2015 As the Mayo ... be discussed, Ford & Associates Nationwide Legal Services, A.P.C., ... 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case ... California. , “In light of a recently filed ... Benicar to evaluate and explore the Mayo Clinic's Benicar ...
(Date:3/5/2015)... PCR (dPCR) and qPCR market is expected to reach $3.97 billion ... The global digital PCR (dPCR) and qPCR market is estimated to ... the mature markets such as the U.S., Germany, France and U.K.) ... the Asia-Pacific region is expected to grow at the highest CAGR ... PCR (dPCR) and qPCR market is driven by factors such as ...
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a leading ... market, reported record revenue of $4.79 million for the ... million in the year-ago fourth quarter demonstrating the Company’s ... strong fourth quarter revenue growth reflects the market’s growing ... driving increased surgeon adoption of our unique product portfolio ...
Breaking Medicine News(10 mins):Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4
(Date:3/5/2015)... SAN DIEGO , March 5, 2015 /PRNewswire/ ... company engaged in the development of biosimilar therapeutics ... announced today that its fourth quarter and full ... Monday, March 16, 2015, before the market opens ... management will host a conference call to discuss ...
(Date:3/5/2015)... MOUNTAIN VIEW, Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... fourth quarter and year ended January 3, 2015.  ... 2014, a record for the Company and up 11% from ... were $42.8 million, also a record, up 12% from $38.3 ... fourth quarter was 50.1%, up from 48.6% in the fourth ...
(Date:3/5/2015)... , March 5, 2015  As the pharmaceutical ... regulations, Ethics & Compliance professionals are placing a ... new survey issued today by LRN, the leader ... An overwhelming majority of respondents expressed that clarity ... important component of E&C training programs (57%), trumping ...
Breaking Medicine Technology:Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3
Cached News: